Callan JMB Inc. (CJMB)
| Market Cap | 7.62M -64.6% |
| Revenue (ttm) | 5.38M -13.5% |
| Net Income | -9.94M |
| EPS | -2.08 |
| Shares Out | 5.65M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 139,330 |
| Open | 1.450 |
| Previous Close | 1.480 |
| Day's Range | 1.230 - 1.480 |
| 52-Week Range | 0.650 - 5.610 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 14, 2026 |
About CJMB
Callan JMB Inc., through its subsidiary, Coldchain Technology Services, LLC provides thermal management logistics solutions to the life sciences industry in United States. It offers logistics solutions and services utilized for frozen shipping in the life sciences industry, including personalized medicine, cell therapies, stem cells, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, organs, biopharmaceuticals, infectious substances, and other commodities. The company also provides emergency preparedness services, whi... [Read more]
Financial Performance
In 2025, Callan JMB's revenue was $5.72 million, a decrease of -12.80% compared to the previous year's $6.56 million. Losses were -$7.97 million, 247.3% more than in 2024.
Financial StatementsNews
Callan JMB and Alabama State University Break Ground on Atlas Complex, Launching an Unprecedented Strategic Partnership to Advance U.S. Pharmaceutical Manufacturing and Supply Chain Resilience
This new landmark project is forecast to ultimately generate estimated annual gross revenues of $500 million for the partnership Callan JMB is entitled to receive a 21% participation in the venture, w...
Callan JMB partners with Alabama State University on drug manufacturing
Callan JMB (CJMB) announced a strategic partnership with Alabama State University to support the development of an integrated pharmaceutical manufacturing ecosystem designed to strengthen domestic pha...
Callan JMB and Alabama State University Announce Strategic Partnership to Advance U.S. Pharmaceutical Manufacturing and Supply Chain Resilience
Management believes the initiative could represent a potential $414 million five-year revenue opportunity for Callan JMB while helping establish a next-generation pharmaceutical manufacturing ecosyste...
Callan JMB announces strategic partnership with Alabama State University
Callan JMB (CJMB) announced a strategic partnership with Alabama State University to support workforce development, applied research, and industry collaboration at Atlas Complex by Callan JMB. The col...
Callan JMB Inc. and Alabama State University Partner to Advance Workforce Development, Research, and Pharmaceutical Innovation at the Atlas Complex
Strategic partnership integrates higher education, industry, and workforce development to accelerate pharmaceutical onshoring and strengthen domestic supply chains
Callan JMB Expands Oregon Public Health Support Capabilities Through State VFC Authorization
Approval enhances the Company's ability to receive, prepare, and deploy pediatric-focused medical materials in support of state and local public health initiatives
Callan JMB files $250M mixed securities shelf
17:31 EDT Callan JMB (CJMB) files $250M mixed securities shelf
Callan JMB expands $175,000 per month infrastructure engagement
Callan JMB (CJMB) announced the expansion and extension of an existing long-term public sector infrastructure engagement valued at approximately $175,000 per month over the next six months. The agreem...
Callan JMB Expands Long-Standing Public Sector Infrastructure Engagement
Strategic extension reinforces recurring revenue visibility and growing demand for preparedness, continuity, and cold chain infrastructure Spring Branch, TX, May 20, 2026 (GLOBE NEWSWIRE) -- Callan JM...
Callan JMB announces The Atlas Complex in Alabama
Callan JMB (CJMB) announced Atlas Complex by Callan JMB, a planned 150 acre campus in Marion, Alabama designed to support an increase of pharmaceutical onshoring, medical logistics, and domestic suppl...
Callan JMB Issues Statement on Recently Filed Lawsuit by Eddie Patent Holdings LLC
Spring Branch, TX, April 17, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergency ...
Callan JMB Successfully Deploys Rapid Redistribution of Critical Pharmaceuticals to Combat Localized Disease Outbreaks for Longstanding Customer
Reverse Distribution Coordination Delivered Necessary Medical Supplies to Requesting Jurisdictions through its Established Emergency Preparedness Network
Callan JMB to provide oversight for JKB-122 manufacturing scale-up
Callan JMB (CJMB) announced its role as an independent infrastructure and oversight partner in a collaboration led by DifGen Pharmaceuticals and Aveva Drug Delivery Systems, alongside Biostax Corp and...
Callan JMB Supports U.S. Scale-Up of Multi-Indication Immune Platform with Phase 2b/3 Advancement
Independent oversight reinforces manufacturing, supply chain integrity, and federal readiness for a platform designed to scale across multiple indications
Callan JMB, Attune Biotech partner for clinical trials for lodonal
Callan JMB (CJMB) has agreed with Biostax Corp d/b/a Attune Biotech to support its investigational new drug clinical trials for the treatment of Post-Acute Sequelae of SARS-CoV-2 infection, commonly k...
Callan JMB Stock (CJMB) Rockets 260% on Attune Biotech Deal
Shares in Callan JMB ($CJMB), the Texas-based integrated logistics and fulfillment company, shot through the roof on Thursday after it teamed up with biopharma firm Attune Biotech. CJMB surged 260.71%...
Callan JMB signs strategic teaming agreement with Biostax Corp
Callan JMB (CJMB) announced it has signed a strategic teaming agreement with Biostax Corp d/b/a Attune Biotech, a clinical-stage biopharmaceutical company with a diversified therapeutic pipeline. Call...
Callan JMB announces strategic pivot to cold-chain infrastructure
Callan JMB (CJMB) announced a comprehensive strategic realignment to address the critical infrastructure gap in the global distribution of GLP-1 medications. As the pharmaceutical industry faces a log...
Callan JMB Inc. (NASDAQ:CJMB) Announces Major Strategic Pivot to Cold-Chain Infrastructure for the $100 Billion GLP-1 Pharmaceutical Market; Initiates Retrofitting of Texas cGMP Facility
GALVESTON, TX / ACCESS Newswire / January 12, 2026 / Callan JMB Inc. (NASDAQ:CJMB), a premier provider of vertically integrated temperature-controlled logistics and specialized life sciences fulfillme...
Callan JMB enters agreement to install oral drug delivery equipment in Texas
Callan JMB (CJMB) announced that it has entered a preliminary agreement with the maker of an oral drug delivery system to install its innovative manufacturing equipment in Callan JMB’s cGMP…
Callan JMB expands reclamation operations into food sampling
Callan JMB (CJMB) announced the expansion of its reclamation operations into the food sampling industry. This move is part of Callan JMB’s multi-variant strategic growth initiative designed to extend ...
Callan JMB Expands Logistics Platform Into Food Sampling Sector, Advancing Multi-Variant Growth Strategy
Move leverages the Company's expertise in regulated materials to capture opportunities in sustainable , high-growth consumer markets
Callan JMB upgrades Sentry Monitoring System technology
Callan JMB (CJMB) announced that it has upgraded its Sentry Monitoring System technology with version 4.0 for temperature-sensitive storage to “significantly increase flexibility and accessibility for...
Callan JMB Upgrades Sentry Monitoring System Technology with Sentry 4 for Mobile Temperature Monitoring
Sentry Monitoring System allows for remote monitoring of refrigerators, freezers, and clean room temperatures for high-value pharmaceutical products in pharmacies, hospitals, and emergency preparednes...
Callan JMB to Participate in Upcoming September Conferences
SPRING BRANCH, Texas, Sept. 02, 2025 (GLOBE NEWSWIRE) -- Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare industry and emergen...